Tapewire

Nasdaq · USD

NAGE

Niagen Bioscience, Inc.

Export transactions ↓
Tapewire entity
6146
SEC CIK
0001386570
Parsed reports
206

Last 12 months

Inside the activity.

2 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202520
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 20, 2017 Filed Jul 3, 2017 21:14 UTC GrantStock Options (right to buy) · Derivative 20,000 $0.00 Strike: $3.59 $0.00
Disclosure

SEC source: 0001415889-17-001083 · form4-07032017_020713.xml · derivative · entry 1

Allen Stephen R. · CIK 0001597090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2027-06-20

F1 · derivative.exercise_date: Options vest 100% on June 20, 2018.

Read SEC document
June 20, 2017 Filed Jul 5, 2017 20:35 UTC GrantStock Options (right to buy) · Derivative 20,000 $0.00 Strike: $3.59 $0.00
Disclosure

SEC source: 0001415889-17-001113 · form4-07052017_010745.xml · derivative · entry 1

GUSTAFSON KURT A · CIK 0001462354 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2027-06-20

F1 · derivative.exercise_date: Options vest 100% on June 20, 2018.

Read SEC document
June 20, 2017 Filed Jul 5, 2017 22:14 UTC GrantStock Options (right to buy) · Derivative 20,000 $0.00 Strike: $3.59 $0.00
Disclosure

SEC source: 0001415889-17-001123 · form4-07052017_030713.xml · derivative · entry 1

Rubin Steven D · CIK 0001381874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2027-06-20

F1 · derivative.exercise_date: Options vest 100% on June 20, 2018.

Read SEC document
June 20, 2017 Filed Jul 6, 2017 20:44 UTC
Baxter JeffDirector
GrantStock Options (right to buy) · Derivative 20,000 $0.00 Strike: $3.59 $0.00
Disclosure

SEC source: 0001415889-17-001139 · form4-07062017_010743.xml · derivative · entry 1

Baxter Jeff · CIK 0001615941 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2027-06-20

F1 · derivative.exercise_date: Options vest 100% on June 20, 2018.

Read SEC document
May 24, 2017 Filed May 26, 2017 09:27 UTC PurchaseCommon Stock 2,521,526 $2.60 $6,555,967.60
Disclosure

SEC source: 0000899243-17-014475 · doc4.xml · nonDerivative · entry 1

Pioneer Step Holdings Ltd · CIK 0001705335 · 10% owner

Chau Hoi Shuen Solina Holly · CIK 0001687026 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,059,988

F1 · shares: Pioneer Step Holdings Limited ("Pioneer Step") acquired 2,521,526 shares of the Issuer's common stock at the closing of the second tranche pursuant to the Securities Purchase Agreement, dated April 26, 2017 the ("SPA"), by and among the Issuer, Champion River Ventures Limited ("Champion River") and Pioneer Step, as amended by the First Amendment to Securities Purchase Agreement, dated May 24, 2017 (the "First Amendment"), by and among the Issuer, Champion River and Pioneer Step.

F2 · ownership.direct: The shares are held directly by Pioneer Step. The sole shareholder and sole director of Pioneer Step is Chau Hoi Shuen Solina Holly ("Solina Chau"). Solina Chau disclaims Section 16 beneficial ownership of the securities held by Pioneer Step, except to the extent of her pecuniary interest therein, if any.

Read SEC document
May 24, 2017 Filed May 26, 2017 09:30 UTC
Li Ka Shing10% owner
PurchaseCommon Stock 3,782,288 $2.60 $9,833,948.80
Disclosure

SEC source: 0000899243-17-014476 · doc4.xml · nonDerivative · entry 1

Champion River Ventures Ltd · CIK 0001705321 · 10% owner

Prime Tech Global Ltd · CIK 0001706084 · 10% owner

Mayspin Management Ltd · CIK 0001706083 · 10% owner

Li Ka Shing · CIK 0001686621 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,589,980

F1 · shares: Champion River Ventures Limited ("Champion River") acquired 3,782,288 shares of the Issuer's common stock at the closing of the second tranche pursuant to the Securities Purchase Agreement, dated April 26, 2017 the ("SPA"), by and among the Issuer, Champion River and Pioneer Step Holdings Limited ("Pioneer Step"), as amended by the First Amendment to Securities Purchase Agreement, dated May 24, 2017 (the "First Amendment"), by and among the Issuer, Champion River and Pioneer Step.

F2 · ownership.direct: The shares are held directly by Champion River. The sole shareholder of Champion River is Prime Tech Global Limited ("Prime Tech"), the sole shareholder of Prime Tech is Mayspin Management Limited ("Mayspin"), and the sole shareholder of Mayspin is Li Ka Shing ("Li Ka Shing"). Each of Prime Tech, Mayspin and Li Ka Shing disclaims Section 16 beneficial ownership of the securities held by Champion River, except to the extent of its pecuniary interest therein, if any.

Read SEC document
May 19, 2017 Filed May 22, 2017 23:52 UTC PurchaseCommon Stock 3,000 $3.20 $9,600.00
Disclosure

SEC source: 0001415889-17-000816 · form4-05222017_040552.xml · nonDerivative · entry 1

Allen Stephen R. · CIK 0001597090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Read SEC document
April 06, 2017 Filed Apr 7, 2017 20:22 UTC GrantEmployee Stock Options (right to buy) · Derivative 40,000 $0.00 Strike: $2.58 $0.00
Disclosure

SEC source: 0001415889-17-000629 · form4-04072017_010420.xml · derivative · entry 1

Rubin Steven D · CIK 0001381874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2027-04-06

F1 · derivative.exercise_date: Options vest 34% on April 6, 2018, 33% on April 6, 2019 and 33% on April 6, 2020.

Read SEC document
March 20, 2017 Filed Mar 21, 2017 20:33 UTC PurchaseCommon Stock 2,000 $2.81 $5,620.00
Disclosure

SEC source: 0001415889-17-000459 · form4-03212017_010305.xml · nonDerivative · entry 1

Allen Stephen R. · CIK 0001597090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000

Read SEC document
March 12, 2017 Filed Mar 14, 2017 21:26 UTC
Fried Robert NDirector · PRESIDENT, CHIEF STRATEGY OFF.
GrantEmployee Stock Options (right to buy) · Derivative 500,000 $0.00 Strike: $2.72 $0.00
Disclosure

SEC source: 0001415889-17-000415 · form4-03142017_020307.xml · derivative · entry 4

Fried Robert N · CIK 0001417952 · Director · PRESIDENT, CHIEF STRATEGY OFF.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2027-03-12

F4 · kind: The options were awarded pursuant to his employment with the issuer as President and Chief Strategy Officer.

F5 · derivative.exercise_date: Options vest in equal monthly installments over three years.

Read SEC document
March 12, 2017 Filed Mar 14, 2017 21:26 UTC
Fried Robert NDirector · PRESIDENT, CHIEF STRATEGY OFF.
GrantCommon Stock 166,667 $0.00 $0.00
Disclosure

SEC source: 0001415889-17-000415 · form4-03142017_020307.xml · nonDerivative · entry 2

Fried Robert N · CIK 0001417952 · Director · PRESIDENT, CHIEF STRATEGY OFF.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 573,241

F2 · shares: These are shares of restricted stock and were awarded pursuant to his employment with the issuer as President and Chief Strategy Officer. 1/3rd will vest on March 12, 2018, 1/3rd will vest on March 12, 2019 and 1/3rd will vest on March 12, 2020.

Read SEC document
March 12, 2017 Filed Mar 14, 2017 21:26 UTC
Fried Robert NDirector · PRESIDENT, CHIEF STRATEGY OFF.
GrantCommon Stock 339,595 $2.72 $923,698.40
Disclosure

SEC source: 0001415889-17-000415 · form4-03142017_020307.xml · nonDerivative · entry 1

Fried Robert N · CIK 0001417952 · Director · PRESIDENT, CHIEF STRATEGY OFF.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 406,574

F1 · price: Received in exchange for the membership interests of Healthspan Research, LLC ("Healthspan") previously owned by the Reporting Person, valued at $923,697.41, in connection with the acquisition of the outstanding membership interests of Healthspan by ChromaDex Corporation (the "Company") (the "Acquisition"). The number of shares received by the Reporting Person was calculated using the closing bid price per share of the Company's common stock on the NASDAQ Capital Market on the last trading day before the effective date of the Acquisition, rounded up to the nearest share. The closing bid price of the Company's common stock on March 10, 2017, rounded up to the nearest share, was $2.72 per share.

Read SEC document
December 12, 2016 Filed Dec 12, 2016 21:58 UTC
Jaksch Frank L JrDirector · CEO, PRESIDENT
PurchaseCommon Stock 2,000 $2.42 $4,840.00
Disclosure

SEC source: 0001415889-16-007569 · form4-12122016_011209.xml · nonDerivative · entry 1

Jaksch Frank L Jr · CIK 0001437237 · Director · CEO, PRESIDENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 201,557

Read SEC document
November 16, 2016 Filed Nov 18, 2016 21:42 UTC GrantEmployee Stock Options (right to buy) · Derivative 20,000 $0.00 Strike: $2.61 $0.00
Disclosure

SEC source: 0001415889-16-007480 · form4-11182016_011138.xml · derivative · entry 1

Fried Robert N · CIK 0001417952 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2026-11-16

F1 · derivative.exercise_date: Options vest 100% on November 16, 2017.

Read SEC document
November 16, 2016 Filed Nov 18, 2016 16:37 UTC GrantEmployee Stock Options (right to buy) · Derivative 20,000 $0.00 Strike: $2.61 $0.00
Disclosure

SEC source: 0001415889-16-007476 · form4-11182016_011151.xml · derivative · entry 1

BLOCK STEPHEN A · CIK 0001183721 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2026-11-16

F1 · derivative.exercise_date: Options vest 100% on November 16, 2017.

Read SEC document
November 16, 2016 Filed Nov 18, 2016 21:39 UTC
Baxter JeffDirector
GrantEmployee Stock Options (right to buy) · Derivative 20,000 $0.00 Strike: $2.61 $0.00
Disclosure

SEC source: 0001415889-16-007478 · form4-11182016_011158.xml · derivative · entry 1

Baxter Jeff · CIK 0001615941 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2026-11-16

F1 · derivative.exercise_date: Options vest 100% on November 16, 2017.

Read SEC document
November 16, 2016 Filed Nov 18, 2016 21:33 UTC GrantEmployee Stock Options (right to buy) · Derivative 20,000 $0.00 Strike: $2.61 $0.00
Disclosure

SEC source: 0001415889-16-007474 · form4-11182016_011150.xml · derivative · entry 1

Allen Stephen R. · CIK 0001597090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2026-11-16

F1 · derivative.exercise_date: Options vest 100% on November 16, 2017.

Read SEC document
November 14, 2016 Filed Nov 16, 2016 21:16 UTC GrantEmployee Stock Options (right to buy) · Derivative 40,000 $0.00 Strike: $2.88 $0.00
Disclosure

SEC source: 0001415889-16-007441 · form4-11162016_011148.xml · derivative · entry 1

GUSTAFSON KURT A · CIK 0001462354 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2026-11-14

F1 · derivative.exercise_date: Options vest 34% on November 14, 2017, 33% on November 14, 2018 and 33% on November 14, 2019.

Read SEC document
September 01, 2016 Filed Sep 6, 2016 20:17 UTC PurchaseCommon Stock 15,000 $3.39 $50,850.00
Disclosure

SEC source: 0001415889-16-007054 · form4-09062016_010946.xml · nonDerivative · entry 1

Fried Robert N · CIK 0001417952 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,979

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.